Constructing catalytically proficient enzymes from de novo designed proteins
从头设计的蛋白质构建催化效率高的酶
基本信息
- 批准号:BB/R016445/1
- 负责人:
- 金额:$ 64.97万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Enzymes are fundamentally important biological molecules that perform the bulk of the chemical reactions in all living organisms. The are themselves proteins, made up of chains of amino acids, though what differentiates them from proteins is their ability to massively increase the rate of chemical reactions. These reactions power cellular life and are involved in a great number of essential processes that give cells their chemical and physical characteristics. Many enzymes perform chemical reactions which have substantial commercial or medical value, as the products of the transformations may be drugs, fuels or other useful substances or materials. It is often the case that for such important or useful reactions, there are no manmade substances available to catalyse the specific chemical transformations with the same degree of precision or efficiency as enzymes. There are also many chemical transformations for which no enzyme has yet been discovered. Therefore, there is a huge interest in building tailor-made enzymes capable of performing selected chemical reactions. While we have gained an incredibly powerful understanding of natural enzymatic catalysis over the past 100 years, there remains a shortfall in the capabilities of artificial, designed enzymes and those found in nature. We believe that this due, in part, to the prevalent use of naturally evolved proteins as the starting points for creating artificial enzymes. These natural proteins may be fragile, difficult and expensive to purify, inactive out of their cellular environment, chemically sensitive to organic molecules and solvents, and, most significantly, they invariably bring an evolutionary complexity with them that can hinder modification by the enzyme designer. We believe that this evolutionary baggage is not a necessary feature of proteins and enzymes and that in certain cases, it might be preferable to work with proteins untouched by natural selection. Our simple proteins, called maquettes, are small robust protein scaffolds that contain no natural protein sequences, and are therefore free from any complexity imposed by evolution. Typically, we design these maquettes to include a non-protein molecule that imparts its own reactivity onto the scaffold. The heme molecule is a particularly versatile molecule that we include in our designs, and it is present in a plethora of natural enzymes, many of which catalyse exceptionally challenging chemical reactions.With our most recent work, we have used an elementary design process to develop a heme-containing maquette into an active artificial enzyme that functions as well as many natural enzymes for the removal of electrons - oxidation - from a broad range of substrates. It can even perform the detoxification of a common pollutant with higher efficiency than a natural enzyme that has evolved specifically for this purpose. The artificial enzyme is relatively insensitive towards temperature and the presence of organic solvents, and is an excellent starting point for the design of new, cheap and highly efficient biocatalysts that have huge potential in industrial biotechnology. The work we propose here aims to exploit this recent success and develop a diverse range of maquettes that will act as robust artificial enzymes capable of catalysing several commercially valuable and challenging reactions. Informed by the structures and our functional understanding of natural enzymes, we will use powerful new computational methods alongside iterative, experimental approaches to achieve this. Crucially, these include reactions not observed in nature, whereby the resulting products contain unusual and highly strained ring structures, and have significant biological activities (e.g. drugs, insecticides). Since the maquettes are fully and functionally assembled in bacteria, we can also employ powerful, high throughput laboratory evolution strategies to improve catalytically activity in a semi random manner.
酶是从根本上重要的生物分子,它们在所有生物体中执行大部分化学反应。它们本身是由氨基酸链组成的蛋白质,尽管它们与蛋白质的区别在于它们大大提高化学反应速率的能力。这些反应为细胞寿命提供动力,并参与了许多基本过程,这些过程赋予细胞化学和物理特征。许多酶进行的化学反应具有大量的商业或医学价值,因为转化的产物可能是药物,燃料或其他有用的物质或材料。通常,对于如此重要或有用的反应,没有人为的物质可以以与酶相同的精度或效率来催化特定的化学转化。还有许多化学转化,尚未发现酶。因此,人们对构建能够执行选定化学反应的量身定制的酶有很大的兴趣。在过去的100年中,我们对自然酶促催化的理解非常有力,但人工,设计酶和自然界中发现的酶的能力仍然存在不足。我们认为,这部分归因于普遍使用自然进化的蛋白作为创建人工酶的起点。这些天然蛋白质可能是脆弱的,难以纯化的,不活跃的,从其细胞环境中进行化学敏感,对有机分子和溶剂化学敏感,最重要的是,它们总是会带来与它们的进化复杂性,从而通过酶设计器来阻碍修饰。我们认为,这种进化行李不是蛋白质和酶的必要特征,在某些情况下,最好使用自然选择不受欢迎的蛋白质。我们的简单蛋白质(称为maquettes)是不包含天然蛋白质序列的小鲁棒蛋白支架,因此没有进化带来的任何复杂性。通常,我们设计了这些小块以包括一个非蛋白质分子,该分子将其自身反应性赋予脚手架。血红素分子是我们在设计中包含的特别用途的分子,它存在于许多天然酶中,其中许多酶催化了许多极具挑战性的化学反应。在我们的最新作品中,我们使用基本设计过程来将血红素conte的杂物造成自然式的杂货 - 以及一种自然的杂物 - 以及一种自然的启用 - 以及一种自然的启用 - 以及一种自然的作用 - 以及一种自然的作用 - 以及一种自然的作用 - 以及一种自然的作用 - 以及一种自然的作用 - 以及一种自然的作用 - 以及一种自然的作用。底物。它甚至可以比专门为此目的而发展的天然酶执行具有更高效率的常见污染物的排毒。人造酶对温度和有机溶剂的存在相对不敏感,并且是设计新型,廉价且高效的生物催化剂的绝佳起点,它们在工业生物技术方面具有巨大的潜力。我们在这里提出的工作旨在利用这一最近的成功,并开发出多种多样的小伙子,将充当强大的人工酶,能够催化几种商业上有价值且具有挑战性的反应。在结构和我们对天然酶的功能理解的情况下,我们将使用强大的新计算方法以及迭代的实验方法来实现这一目标。至关重要的是,这些反应在自然界中未观察到,因此所产生的产品包含异常和高度应变的环结构,并具有重要的生物学活性(例如药物,杀虫剂)。由于小块在细菌中完全且功能地组装,因此我们还可以采用强大的高吞吐量实验室进化策略,以半随机的方式改善催化活性。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An expandable, modular de novo protein platform for precision redox engineering.
- DOI:10.1073/pnas.2306046120
- 发表时间:2023-08
- 期刊:
- 影响因子:11.1
- 作者:Hutchins, George H.;Noble, Claire E. M.;Bunzel, H. Adrian;Williams, Christopher;Dubiel, Paulina;Yadav, Sathish K. N.;Molinaro, Paul M.;Barringer, Rob;Blackburn, Hector;Hardy, Benjamin J.;Parnell, Alice E.;Landau, Charles;Race, Paul R.;Oliver, Thomas A. A.;Koder, Ronald L.;Crump, Matthew P.;Schaffitzel, Christiane;Oliveira, A. Sofia F.;Mulholland, Adrian J.;Anderson, J. L. Ross
- 通讯作者:Anderson, J. L. Ross
Evolution of dynamical networks enhances catalysis in a designer enzyme
- DOI:10.1101/2020.08.21.260885
- 发表时间:2020-01-01
- 期刊:
- 影响因子:0
- 作者:Bunzel, H. A.;Anderson, J. L. R.;Mulholland, A. J.
- 通讯作者:Mulholland, A. J.
Rigidifying a De Novo Enzyme Increases Activity and Induces a Negative Activation Heat Capacity.
- DOI:10.1021/acscatal.1c01776
- 发表时间:2021-09-17
- 期刊:
- 影响因子:12.9
- 作者:Hindson SA;Bunzel HA;Frank B;Svistunenko DA;Williams C;van der Kamp MW;Mulholland AJ;Pudney CR;Anderson JLR
- 通讯作者:Anderson JLR
Antibodies generated in vitro and in vivo elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine
- DOI:10.1101/2023.03.17.533092
- 发表时间:2023-03
- 期刊:
- 影响因子:0
- 作者:Dora Buzas;H. Bunzel;Oskar Staufer;E. Milodowski;Grace Edmonds;beatriz Vidana Matteo;C. Schaffitzel;Sathish K. N. Yadav;K. Gupta;Charlotte Fletcher;M. Williamson;Alexandra Harrison;Ufuk Borucu;Julien Capin;Ore Francis;Georgia Balchin;Sophie Hall;Mirella Vivoli Vega;F. Durbesson;R. Vincentelli;Joe Roe;L. Wooldridge;R. Burt;Ross J L Anderson;A. Mulholland;J. Hare;Mick Bailey;A. Davidson;A. Finn;David Morgan;Jamie F S Mann;Joachim P. Spatz;F. Garzoni;J. Bufton;I. Berger
- 通讯作者:Dora Buzas;H. Bunzel;Oskar Staufer;E. Milodowski;Grace Edmonds;beatriz Vidana Matteo;C. Schaffitzel;Sathish K. N. Yadav;K. Gupta;Charlotte Fletcher;M. Williamson;Alexandra Harrison;Ufuk Borucu;Julien Capin;Ore Francis;Georgia Balchin;Sophie Hall;Mirella Vivoli Vega;F. Durbesson;R. Vincentelli;Joe Roe;L. Wooldridge;R. Burt;Ross J L Anderson;A. Mulholland;J. Hare;Mick Bailey;A. Davidson;A. Finn;David Morgan;Jamie F S Mann;Joachim P. Spatz;F. Garzoni;J. Bufton;I. Berger
Expression and In Vivo Loading of De Novo Proteins with Tetrapyrrole Cofactors.
使用四吡咯辅因子表达和体内装载 De Novo 蛋白质。
- DOI:10.1007/978-1-0716-1826-4_8
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Curnow P
- 通讯作者:Curnow P
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ross Anderson其他文献
No Easy Way Out: The Effectiveness of Deplatforming an Extremist Forum to Suppress Hate and Harassment
没有简单的出路:消除极端主义论坛平台以抑制仇恨和骚扰的有效性
- DOI:
10.48550/arxiv.2304.07037 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
A. V. Vu;Alice Hutchings;Ross Anderson - 通讯作者:
Ross Anderson
THE APPLICATION OF DETREMDED FLUCTUATION ANALYSIS IN RUNNING AND ITS INTEGRATION INTO A REAL-TIME SYSTEM
确定波动分析在运行中的应用及其与实时系统的集成
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
M. Norris;A. Amado;Joseph Harmill;Ian Kenny;Ross Anderson - 通讯作者:
Ross Anderson
A Wet Cold-Flow Technology for Tackling Offshore Flow-Assurance Problems
用于解决海上流量保证问题的湿冷流技术
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
R. Azarinezhad;A. Chapoy;Ross Anderson;B. Tohidi - 通讯作者:
B. Tohidi
931 GENOMIC SIGNATURE CORRELATING SENSITIVITY OF BLADDER CANCER CELL LINES TO EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS
- DOI:
10.1016/j.juro.2013.02.508 - 发表时间:
2013-04-01 - 期刊:
- 影响因子:
- 作者:
Trevor Levin;Jim Korkola;Tiera Liby;Jeffery LaRochelle;Ross Anderson;Steven McNamara;Christopher Amling;Joe Gray;Theresa Koppie - 通讯作者:
Theresa Koppie
Hextend and 7.5% hypertonic saline with Dextran are equivalent to Lactated Ringer's in a swine model of initial resuscitation of uncontrolled hemorrhagic shock.
Heextend%20和%207.5%%20高渗%20盐水%20和%20葡聚糖%20是%20当量%20至%20乳酸%20林格氏%20in%20a%20猪%20模型%20of%20初始%20复苏%20of%20不受控制%20出血%20休克。
- DOI:
10.1097/ta.0b013e3182367b1c - 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
G. Riha;Nicholas R. Kunio;Philbert Y. Van;Gregory J. Hamilton;Ross Anderson;J. Differding;M. Schreiber - 通讯作者:
M. Schreiber
Ross Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ross Anderson', 18)}}的其他基金
Creating and comprehending the circuitry of life: precise biomolecular design of multi-centre redox enzymes for a synthetic metabolism
创建和理解生命回路:用于合成代谢的多中心氧化还原酶的精确生物分子设计
- 批准号:
BB/W003449/1 - 财政年份:2022
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Tracking Covid Cybercrime and Abuse
追踪 Covid 网络犯罪和滥用行为
- 批准号:
EP/V026178/1 - 财政年份:2020
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Interdisciplinary Centre for Finding, Understanding and Countering Crime in the Cloud
寻找、理解和打击云端犯罪的跨学科中心
- 批准号:
EP/M020320/1 - 财政年份:2015
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Building Solar-Powered, Carbon-Fixing Protoalgae
构建太阳能固碳原藻
- 批准号:
BB/M02315X/1 - 财政年份:2015
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
The Deterrence of Deception in Socio-Technical Systems
社会技术系统中欺骗的威慑
- 批准号:
EP/K033476/1 - 财政年份:2013
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Assembly of Artificial Oxidoreductases
人工氧化还原酶的组装
- 批准号:
BB/I014063/1 - 财政年份:2011
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
Measuring the Security of Internet Infrastructure
衡量互联网基础设施的安全性
- 批准号:
EP/H018298/1 - 财政年份:2010
- 资助金额:
$ 64.97万 - 项目类别:
Research Grant
相似国自然基金
锡(铋、铟)氧/硫化物在CO2电还原过程中的重构行为与催化机制研究
- 批准号:52372217
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于共价有机框架的噬菌体-光催化协同靶向抗菌策略用于顽固性细菌感染的研究
- 批准号:22378279
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
二元金属原子团簇协同催化多硫化锂转化机制研究
- 批准号:22379001
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
cMOFs/Pd-LDHs异质结的导向制备及其电催化硝酸盐合成氨研究
- 批准号:22368002
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
ビタミンAの過剰摂取によるSUMO化制御異常を介した催奇形性機構の探索
维生素A过量摄入导致SUMO化调节异常介导的致畸机制探讨
- 批准号:
24KJ2134 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Grant-in-Aid for JSPS Fellows
化学物質のシグナルかく乱作用を基にした新規in vitro催奇形性評価原理の解明
阐明基于化学物质信号干扰作用的体外致畸评价新原理
- 批准号:
23K25021 - 财政年份:2024
- 资助金额:
$ 64.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Catalytically Generated Amidyl Radicals for Site-Selective Intermolecular C-H Functionalization
催化生成酰胺自由基用于位点选择性分子间 C-H 官能化
- 批准号:
10679463 - 财政年份:2023
- 资助金额:
$ 64.97万 - 项目类别:
CAREER: CAS: Organometallic Chemistry of Catalytically Relevant Copper(III) Complexes
职业:CAS:催化相关铜 (III) 配合物的有机金属化学
- 批准号:
2237757 - 财政年份:2023
- 资助金额:
$ 64.97万 - 项目类别:
Continuing Grant
Mulitifaceted Testing of the Mechanism of Action of Hypnosis for Chronic Pain Based on the Behavioral Inhibition System and Behavioral Activation System (BIS-BAS) Model.
基于行为抑制系统和行为激活系统(BIS-BAS)模型的催眠治疗慢性疼痛的作用机制的多方面测试。
- 批准号:
23H01040 - 财政年份:2023
- 资助金额:
$ 64.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)